Why Female Bodybuilders Are Dying and the Bloodwork That Warns You

A Brazilian clip about the death of Spanish bikini pro Lorena Blanco has been recirculating this month, and the comments under it split into two camps. One says it was the water pills. The other says it was the gear. Both are partly right, and neither explains what actually happens inside a competitor's body in the last week before a show.
This article covers the first real data on deaths among female competitors, why the heart is the organ that gives out, how electrolyte swings turn a thickened heart into an unstable one, and the bloodwork that tells you, months before a show, whether your body can handle the week.
This is harm-reduction education, not medical advice. Prescription water pills, blood pressure drugs and extreme water manipulation are linked to hospitalisations and deaths in competitors. Do not use them for a show. If you compete, do it with a doctor who has your bloodwork, not just a coach.
Quick answer: A 2025 study of 9,447 female IFBB competitors found sudden cardiac death was the most common cause of death, about 31% of the total, and professionals carried more than 20 times the risk of amateurs. The pattern behind it is a heart thickened and weakened by steroids, hit in peak week by swings in potassium, sodium and magnesium from water and drug manipulation. Before any prep, get electrolytes, kidney function with cystatin C, haematocrit, an ECG and ideally an echo. If a coach prescribes drugs without asking for bloods, walk. Full evidence and checklist below.
What the numbers say about female competitors dying
Until last year there was no hard data on women. In October 2025 a research group in Padova, which had already published on male bodybuilders, released a study in the European Heart Journal covering 9,447 women who competed in at least one IFBB event between 2005 and 2020 (Vecchiato et al., 2026). According to the paper and the European Society of Cardiology's summary:
- 32 deaths were identified, at a mean age of about 42.
- Sudden cardiac death was the most common cause, roughly 31% of deaths.
- Professionals had more than 20 times the sudden cardiac death risk of amateurs.
- Suicide and homicide made up about 13% of deaths, four times the male figure.
- Autopsy findings were available for only a small share of the deaths.
The men's study from the same group is larger: 20,286 male IFBB athletes, 121 deaths, about 38% of them sudden cardiac deaths, with autopsies showing enlarged, thickened hearts (Vecchiato et al., 2025). Women's rates are lower than men's, but the pattern of young, sudden cardiac deaths is the same.
Two caveats. Deaths were found by searching the web, so the real number is almost certainly higher. And the study did not record which drugs anyone used, so it cannot pin any death on a particular substance. What it does show is that physique athletes, women included, are dying young and suddenly from their hearts, and that the risk climbs sharply at the pro level, where the drug use and the peak weeks get more extreme.
What we know about Lorena Blanco
Lorena Blanco was a 37-year-old IFBB bikini pro from Spain. She died on 26 July 2025, and outlets reported a heart attack at home (BarBend, Generation Iron). No autopsy, toxicology or official cause of death has been published, so nobody outside her family knows what killed her, and we are not going to guess. The clip does make one fair point about her schedule. She turned pro in 2023 and competed several times a year after that. More on show frequency below.
Why the heart is the weak point
Anabolic steroids change the heart's structure. It is a muscle with androgen receptors, and it responds to them.
The clearest data come from men. In a Circulation study of long-term users, the left ventricle's pumping strength (ejection fraction) averaged 52% against 63% in non-users, relaxation was impaired, and users had more coronary plaque (Baggish et al., 2017). The Dutch HAARLEM study scanned men before and after a single cycle: ejection fraction fell about 5 points and left ventricular mass rose by 28 g on average, scaling with weekly dose (Smit et al., 2021). The good news from HAARLEM is that most of it reversed after about 8 months off. A Danish study is less reassuring: former users still showed subtly weaker contraction around two and a half years after stopping (Rasmussen et al., 2018).
Autopsy series of steroid users show the same picture taken further: heavier hearts after adjusting for body size (Far et al., 2012), and thickened walls with patches of scarring that the pathologists describe as a classic setting for dangerous heart rhythms (Montisci et al., 2012).
What about women?
Here the data are thin. The only cardiac imaging study we found that included women was a 2025 Danish study in which about a quarter of the steroid users were female. Each extra year of cumulative use raised the odds of coronary plaque, and heart function worsened with total exposure, "in both sexes" (Buhl et al., 2025). A Dutch chart review of 41 women at a harm-reduction clinic found most were amateur bodybuilders using mainly oxandrolone at lower doses than men, often alongside clenbuterol, thyroid hormone and growth hormone (Verdegaal et al., 2026). Lower doses may mean less heart remodelling, but nobody has measured that, and clenbuterol and T3 both add their own load on heart rate and rhythm.
The video's narrator makes the point that bikini judging has moved toward more muscle over the years. If that pushes women toward higher doses and more compounds, it moves them closer to the male data above.
How peak week turns a changed heart into an unstable one
Think of it as a substrate and a trigger. Steroids, stimulants and years of hard dieting build the substrate: a thicker, stiffer heart with less margin. Peak week supplies the trigger.
The heart's rhythm runs on a narrow band of electrolytes, above all potassium. Too high and the electrical signal slows and can stop. Too low, especially with low magnesium alongside, and the heart becomes irritable and prone to fast, chaotic rhythms. Classic peak-week manipulation pushes on both ends at once: drinking very large volumes and then cutting fluid, cutting sodium, and taking drugs that change how the kidneys handle water and salts. Some of the drugs competitors misuse make the body hold on to potassium, others make it pour potassium out, and taking fluid away removes the kidneys' ability to correct either mistake.
This is not theoretical. Doctors know that stacking two classes of heart and blood pressure drugs that both raise potassium is dangerous even in supervised patients: when that combination became common in Ontario after a 1999 trial, hospital admissions for high potassium rose from 2.4 to 11.0 per 1,000 patients and related deaths from 0.3 to 2.0 per 1,000 (Juurlink et al., 2004). Those were monitored patients. A competitor in peak week usually has no monitoring at all.
Bodybuilding has its own case reports in both directions. A 31-year-old male bodybuilder collapsed with a heart attack, a potassium of 6.7 mmol/L and a run of ventricular tachycardia (Appleby et al., 1994). A professional bodybuilder in Austria arrived at hospital paralysed by potassium that had fallen too low (Mayr et al., 2012). A study of Brazilian competitors found water-pill and steroid use in peak week was common and near-identical among athletes sharing a coach, which tells you these are templates handed down, not individual decisions (Almeida et al., 2023).
Worse, you often cannot feel it coming. In a review of patients with potassium of 6.0 or above, the ECG was an unreliable early warning, and no single threshold predicted who would show changes (Montague et al., 2008). Feeling fine on Saturday says nothing about your potassium.
Peak week does not need drugs or a water cut to work. Most of the "dry, full" look comes from glycogen pulling water into the muscle. Our peak week carb loading guide covers how to do that with steady water and sodium, and why water restriction often flattens you out instead.
Enjoying this article?
Get evidence-based bloodwork guides delivered to your inbox every two weeks. No spam, unsubscribe anytime.
How many shows a year is too many?
There is no study that says four shows a year is dangerous, so we will not pretend there is. But the recovery data all point the same way.
A year-long case study of a natural competitor saw resting heart rate fall from 53 to 27 bpm and testosterone collapse during prep, with most measures taking around six months to recover after the show (Rossow et al., 2013). Interviews with physique athletes found recovery from long periods of low energy intake is hard, poorly guided, and easy to rationalise away (Buechel et al., 2025). And the HAARLEM heart changes took about eight months off-cycle to reverse.
Put those together and competing every two or three months means the body, and the heart, never gets back to baseline. Each peak week lands on a system that is still depleted from the last one. The video's advice here is sound: fewer shows, longer off-seasons, and treat recovery as its own phase.
What your bloodwork should show before a prep
This is the part you can act on. Run it at the start of prep, again around four weeks out, and once more 7 to 10 days before the show, while there is still time to change course.
| Marker | Typical range | Talk to a doctor before going further if |
|---|---|---|
| Potassium | 3.5 to 5.0 mmol/L | Above 5.0 or below 3.5 |
| Sodium | 135 to 145 mmol/L | Below 135 |
| Magnesium | about 0.7 to 1.0 mmol/L | Below 0.7 |
| Creatinine and eGFR | Runs high in muscular athletes | eGFR below 60, or creatinine up sharply on your own baseline |
| Cystatin C | Lab range | Raised, which points to real kidney strain rather than muscle mass |
| Haematocrit | Women about 0.36 to 0.46 | Above 0.50, since dehydration pushes it higher still |
| Blood pressure | Below 130/80 | Persistently high on cycle |
Add a resting ECG and, if you use steroids, an echocardiogram well before the show. These look at what bloodwork cannot: wall thickness, pumping strength and rhythm. Cardiac blood markers like NT-proBNP and troponin can rise after hard training in healthy athletes, so on their own they are not a reliable screen. Use them alongside the ECG and echo, not instead of them.
For kidney numbers, muscle mass inflates creatinine and makes eGFR look worse than it is. Cystatin C is far less affected by muscle, and the combined creatinine and cystatin C equation is the better estimate when creatinine is unreliable (Inker et al., 2021). We explain why in why muscular athletes get false kidney failure diagnoses. A rise in creatinine of 26.5 umol/L within 48 hours meets the formal definition of acute kidney injury (Khwaja, 2012), so track yours against your own baseline, not just the lab range.
What if my potassium comes back 5.4 a week out?
First, repeat it. Potassium is one of the easiest results to falsely raise: clenching your fist during the draw, a tight tourniquet, a slow trip to the lab or a haemolysed sample can all push it up (Saleh-Anaraki et al., 2022). Ask for a repeat with a relaxed hand and check whether the report flags haemolysis.
If the repeat is still above 5.0, treat it as real. Check your eGFR and cystatin C, list every drug and supplement you are taking (including potassium salts and "electrolyte" products), and see a doctor before show week. A potassium of 5.5 or above, or any palpitations, weakness or dizziness, needs medical attention now, not after the show. At that point no placing is worth it.
What if my sodium or magnesium is low?
Sodium below 135 means you are already diluted. More water loading on top of it is how competitors and endurance athletes end up with confusion, seizures and brain swelling (Spasovski et al., 2014). Low magnesium matters because it makes low potassium harder to correct and adds to rhythm risk (Whang et al., 1994). Both are reasons to keep water and sodium steady through the week and to fix the deficit with your doctor first.
Support My TRT
Found this helpful? Keep the articles (and my TRT) going.
Buy Me a CoffeeOr donate crypto
bc1qhd…u5gp0x12CE…C1e4Send only the matching coin to each address. More ways to support
Choosing a coach who asks for your bloods
The line from the video worth keeping: if a coach puts you on a stack of drugs without ever asking for a blood test, leave. A good coach will:
- Ask for baseline bloodwork, including electrolytes and kidney function, before prescribing anything.
- Want an ECG, and an echo if you are using steroids.
- Plan peak week around food and steady water, not prescription drugs.
- Be fine with you running the plan past your doctor.
- Care about your health after the show, not just their placings.
Competing at a high level is a choice adults are entitled to make. Going into it without knowing what your heart and kidneys look like is not a risk you need to take. If you are using oxandrolone or stanozolol, our bloodwork guide for women on Anavar covers the rest of the panel, and how to lower blood pressure on cycle covers the cardiovascular side with a doctor.
Log your prep bloodwork and see the trend
Upload each panel through prep and VitalMetrics flags potassium, sodium, kidney and haematocrit changes against your own baseline, so a bad trend shows up weeks before show day, not on it.
Try it FreeKey takeaways
- In 9,447 female IFBB competitors, sudden cardiac death was the most common cause of death, about 31%, and pros carried more than 20 times the risk of amateurs.
- Lorena Blanco's cause of death has never been published. Nobody can say what killed her.
- Steroids thicken and weaken the heart; in men, pumping strength averaged 52% vs 63% in non-users. Data in women are thin but point the same way.
- Peak-week water and drug manipulation swings potassium, sodium and magnesium, which is the trigger a remodelled heart handles worst.
- Competing every few months means never recovering to baseline.
- Before prep: electrolytes, creatinine with cystatin C, haematocrit, blood pressure, ECG, and an echo if you use steroids. Repeat 7 to 10 days out.
- Any coach who prescribes drugs without bloodwork is a reason to leave.

Found this helpful? Keep the articles (and my TRT) going.
References
- Vecchiato, M., Ermolao, A., Zane, L., Giagio, S., Aghi, A., Palermi, S., Borasio, N., Zorzi, A., & Neunhaeuserer, D. (2026). Mortality in female bodybuilding athletes. European Heart Journal, 47(3), 373-375. PubMed
- Vecchiato, M., Ermolao, A., Da Col, M., et al. (2025). Mortality in male bodybuilding athletes. European Heart Journal, 46(30), 3006-3016. PubMed
- Baggish, A. L., Weiner, R. B., Kanayama, G., et al. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991-2002. PubMed
- Smit, D. L., Voogel, A. J., den Heijer, M., & de Ronde, W. (2021). Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction: echocardiography results of the HAARLEM study. Frontiers in Reproductive Health, 3, 732318. PubMed
- Rasmussen, J. J., Schou, M., Madsen, P. L., et al. (2018). Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids. American Heart Journal, 203, 49-56. PubMed
- Far, H. R., Ågren, G., & Thiblin, I. (2012). Cardiac hypertrophy in deceased users of anabolic androgenic steroids. Cardiovascular Pathology, 21(4), 312-316. PubMed
- Montisci, M., El Mazloum, R., Cecchetto, G., et al. (2012). Anabolic androgenic steroids abuse and cardiac death in athletes. Forensic Science International, 217(1-3), e13-e18. PubMed
- Buhl, L. F., et al. (2025). Illicit anabolic steroid use and cardiovascular status in men and women. JAMA Network Open. PubMed
- Verdegaal, T. J., et al. (2026). Androgen use among female amateur athletes: a retrospective analysis. Scandinavian Journal of Medicine & Science in Sports. PubMed
- Juurlink, D. N., Mamdani, M. M., Lee, D. S., et al. (2004). Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. New England Journal of Medicine, 351(6), 543-551. PubMed
- Appleby, M., Fisher, M., & Martin, M. (1994). Myocardial infarction, hyperkalaemia and ventricular tachycardia in a young male body-builder. International Journal of Cardiology, 44(2), 171-174. PubMed
- Mayr, F. B., Domanovits, H., & Laggner, A. N. (2012). Hypokalemic paralysis in a professional bodybuilder. American Journal of Emergency Medicine, 30(7), 1324.e5-8. PubMed
- Almeida, F. N., et al. (2023). Training, pharmacological ergogenic aids, dehydration, and nutrition strategies during a peak week in competitive Brazilian bodybuilders. Sports, 12(1), 11. PubMed
- Montague, B. T., Ouellette, J. R., & Buller, G. K. (2008). Retrospective review of the frequency of ECG changes in hyperkalemia. Clinical Journal of the American Society of Nephrology, 3(2), 324-330. PubMed
- Rossow, L. M., Fukuda, D. H., Fahs, C. A., Loenneke, J. P., & Stout, J. R. (2013). Natural bodybuilding competition preparation and recovery: a 12-month case study. International Journal of Sports Physiology and Performance, 8(5), 582-592. PubMed
- Buechel, C., et al. (2025). The harder the prep, the harder the recovery. Journal of the International Society of Sports Nutrition. PubMed
- Inker, L. A., Eneanya, N. D., Coresh, J., et al. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 385(19), 1737-1749. PubMed
- Khwaja, A. (2012). KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 120(4), c179-c184. PubMed
- Saleh-Anaraki, K., Jain, A., Wilcox, C. S., & Pourafshar, N. (2022). Pseudohyperkalemia: three cases and a review of literature. American Journal of Medicine, 135(7), e150-e154. PubMed
- Spasovski, G., Vanholder, R., Allolio, B., et al. (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology, 170(3), G1-G47. PubMed
- Whang, R., Hampton, E. M., & Whang, D. D. (1994). Magnesium homeostasis and clinical disorders of magnesium deficiency. Annals of Pharmacotherapy, 28(2), 220-226. PubMed
Related reading
More guides on the same markers and compounds.
Stay on top of your bloodwork
Get evidence-based articles on bloodwork, TRT, and harm reduction delivered to your inbox every two weeks.


